May 21, 2020 / 6:37 AM / 16 days ago

Slovenia's Krka Q1 net profit up by 21%

LJUBLJANA, May 21 (Reuters) - Slovenian generic drug producer Krka on Thursday reported a rise in group net profit to 85.2 million euros ($93.37 million) in the first quarter from 70.3 million a year earlier.

Sales rose 22% to 462.9 million euros boosted by an increased used of pharmaceuticals amid the coronavirus epidemic with sales in southeastern Europe up 27%.

Krka confirmed its November forecast calling for a profit this year of some 210 million euros on sales of 1.5 billion.

$1 = 0.9125 euros Reporting by Marja Novak; editing by Jason Neely

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below